newdrugapprovals.org
Ivosidenib,  ивосидениб , إيفوزيدينيب , 艾伏尼布 , 
Ivosidenib AG-120; TIBSOVO FDA approves first targeted treatment Tibsovo (ivosidenib) for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation The U.S. Fo…